Biocracked
**Approach 1: Macro science, Palette D: Bold color field**

Extreme macro photograph of a single human scalp hair strand, shot at a slight diagonal. It is pigmented dark brown at the root and fades into silvery-white along its length, with the cuticle scales and fine texture visible. Beside it, a few pure white strands cross the frame. The backdrop is a smooth, saturated mustard-yellow field with no pattern. A soft, wide key light from the upper left gives the strands a glossy, translucent sheen and a gentle shadow on the yellow. Shallow depth of field blurs the far end of the hair into creamy softness. One tiny electric green droplet of serum clings to the strand near the root, catching a bright highlight. The mood is crisp, curious and optimistic, with a scientific tone.
Supplements

Rambut Abang Mudhun 13 % sajrone 24 Minggu kanthi Kombinasi Pil lan Serum

Nova Chen · · 4 min read

Yen angka sing paling maringi pangertosan saka uji coba rambut abu‑abu ora pira rambut sing dadi luwih apik, nanging pira kelompok plasebo sing malah dadi luwih parah? Ing studi acak, double‑blind anyar, wong sing njupuk suplemen lan ngginakaké serum ndelok jumlah rambut abu‑abu mudhun 13,0 % sajrone 24 minggu. Wong sing nampa plasebo ganda malah ndeleng kenaikan 9,7 % luwih abu‑abu tinimbang nalika wiwitan.

Studi iki diterbitaké ing Journal of Drugs in Dermatology (2026) lan misuwur amarga klaimé. Para pangarang ngandhakaké yèn sadurungé durung ana perawatan klinis sing kabukten bisa mbalekaké warna utawa nglambataké munculé rambut abu‑abu.

Masalahé: Rambut Abang Kira‑kira Sakabèhé

Ing sak ndonya, 74 % wong lanang lan wadon umur 45‑65 taun wis nduwèni rambut abu‑abu. Sanajan umum, para panliti nyathet yèn saiki durung ana perawatan sing didhukung bukti klinis kanggo mbalekaké warna rambut utawa nglambataké proses abu‑abu. Pasar mayoritas mung ngandhut pewarna sing nutupi abu‑abu tinimbang ngrampungaké panyebabé.

Kekosongan iki sing dicoba diisi déning trial iki, kanthi regimen loro bagéyan saka Two Lines Inc.: To The Root® serum (topikal) lan Not Today Grey (suplemen oral).

Carane Uji Coba Digawe

Desainé luwih kuwat tinimbang akèh studi produk konsumen:

  • 173 priya lan wanita umur 28 nganti 65 taun melu studi iki
  • Kabeh peserta nduwèni 5 %–25 % rambut abu‑abu nalika wiwitan, dadi tingkat abu‑abu sing isih awal nganti menengah, ora nganti kebak abu‑abu
  • Studi iki randomized, double‑blind lan kontrol plasebo
  • Dilakokaké suwéné 24 minggu, kanthi paling ora 40 peserta ing saben papat klompok

Paparan papat klompok yaiku:

  1. Kombinasi: suplemen + serum
  2. Mung suplemen: suplemen + serum plasebo
  3. Mung serum: serum + suplemen plasebo
  4. Plasebo: suplemen plasebo + serum plasebo

Susunan papat klompok iki maringi kesempatan kanggo nyelidiki apa loro produk bisa makarya dewekan utawa perlu bebarengan.

Angka‑Angka Utama

Asil saka grup kombinasi:

  • Minggu 12: penurunan 9,2 % saka jumlah rambut abu‑abu (P = 0,034 dibandingaké karo baseline)
  • Minggu 24: penurunan 13,0 % (P = 0,016 dibandingaké karo baseline)

Kelompok plasebo ngalami kenaikan 9,7 % saka jumlah rambut abu‑abu saka baseline nganti minggu 24. Perbandingan antarane grup kombinasi karo plasebo ing minggu 24 ngasilaké P = 0,004, nuduhaké béda statistik sing signifikan.

Para panliti nerangaké asil kombinasi iki minangka loro‑loro statistik lan klinis penting.

Ora Mung Nglitung Cacah Rambut

Patut dipertimbangaké apa pangukuran cacah rambut iki ora mung subyektif utawa kebisingan. Penulis nyebutaké loro ukuran liya sing nuduhaké arah sing padha:

  • Penilaian foto rambut abu‑abu: P = 0,002 kanggo minggu 24 vs baseline
  • Observasi dhéwé (penilaian peserta): P = 0,002 vs baseline

Nalika grading objektif lan persepsi peserta sarujuk, temuan iki luwih angel dibantah mung amarga cara ngétung.

Cathetan Cilik: Kombinasi, Dudu Produk Individu

Abstrak nyatakake asil iki amarga “efek sinergis” saka campuran proprietary ing suplemen lisan lan serum topikal sing dipatenake. Manfaat iki mung kabuktèkaké kanggo kombinasi. Abstrak ora nglaporaké efek signifikan kanggo suplemen utawa serum sing dipigunakaké dewekan, mula ora bener yen ngandhakaké suplemen dewekan bisa nyuda rambut abu‑abu.

Loro watesan liyane sing pantes disebutaké:

  • Bahan ora kadhaptar ing abstrak. Produk kasebut mung diterangaké minangka campuran proprietary, dadi ora mungkin kanggo mangertèni apa sing dadi bahan aktif utawa mbandhingaké karo produk liyané.
  • Produk asalé saka siji perusahaan. Studi iki mung nguji produk saka Two Lines Inc. Wacané kudu dipriksa ing bagean pengungkapan lan dana, lan replikasi independèn bakal nambah kapercayan.

Pelajaran Praktis

Tegese Asil Kombinasi

Asil positif mung ana nalika suplemen lan serum dipigunakaké bebarengan. Adhedhasar abstrak, ora kena nganggep yen mung siji produk bisa ngasilaké efek sing padha.

Tetepake Ekspektasi Realistis

Penurunan 13,0 % ing cacah rambut abu‑abu iku penurunan, dudu mbalekaké warna sakabehé. Peserta wiwit karo 5–25 % rambut abu‑abu, lan ora ana bukti yèn rambut sing wis kebak abu‑abu bakal bali dadi warna asli. Pikiraké "sithik luwih sithik abu‑abu tinimbang sadurungé", ora "warna mudha mulih lengkap".

Elinga Perbandingan Plasebo

Kelompok plasebo nambah kira‑kira 10 % luwih abu‑abu ing periode sing padha. Iki ndadékaké béda antarane grup kombinasi lan plasebo luwih gedhé tinimbang angka 13 % piyambak, lan iku sing dipigunakaké penulis kanggo tes signifikan (P = 0,004).

Sapa Sing Cocok Karo Iki

Bukti iki paling pas kanggo wong diwasa umur 28–65 taun sing nduwèni greying awal nganti menengah (5–25 %). Abstrak ora ngomongaké babagan wong sing wis mayoritas rambut abu‑abu utawa putih, mula asil iki ora bisa digeneralisasi kanggo kelompok kuwi.

Tetep Kritis

Siji trial, formula proprietary lan produk siji perusahaan dadi alesan kanggo optimisme tinimbang kapastian. Asil iki menjanjikan, nanging ora dadi alesan kanggo nglirwakaké kewaspadaan marang klaim suplemen. Priksa dhaptar bahan kanggo alèrgi lan rembugan karo dokter sadurunge nambah suplemen, mliginé yèn sampeyan lagi ngonsumsi obat utawa nduwèni kondisi medis.

Ringkesan

Rambut abu‑abu wis suwe dipandang minangka kahanan sing ora bisa dihindari, lan trial iki dadi sinyal awal yèn bisa diatur. Sajrone 24 minggu, regimen suplemen + serum nyuda cacah rambut abu‑abu nganti 13,0 %, dene pangguna plasebo nambah 9,7 %. Langkah sabanjure yaiku replikasi independèn, pengungkapan bahan ing campuran, lan data apa saben produk bisa menehi kontribusi déwékan.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: the human outcome. Palette: natural.

Extreme close-up of a woman's eye and the delicate skin around it, shot from a slight three-quarter angle with a 100mm macro lens and a shallow depth of field. Her skin is a mature 50s complexion with fine crow's feet that are sharp and tactile, with visible pores and soft vellus hairs. Her gaze is relaxed and not at the camera, and the face is cropped so identity isn't the focus. Soft, directional window daylight rakes across the skin from the left to bring out the wrinkle texture, with gentle warm skin tones and a blurred leafy green background outdoors. A single glass of water with a faint dissolving powder swirl sits out of focus in the foreground, with a tiny electric green leaf highlight at the edge. The mood is calm, honest and quietly scientific.
peptides

2,5 g Peptida Kolagen Ngurangi Kerutan Mata 20 % Sajeroning 8 Minggu

BY NOVA CHEN ·

Kolagen iku suplemen kecantikan lan umur panjang sing paling akèh digoleki, nanging mung sithik produk sing kuduné didhukung data klinis kontrol placebo. Ing uji coba iki, 114 wanita umur 45‑65 taun ngombe 2,5 g saben dina Verisol lan volume kerutan mata turun 20 % tinimbang placebo sawisé 8 minggu. Biopsi nuduhaké peningkatan procollagen tipe I nganti 65 % lan elastin nganti 18 %, dene fibrillin mung mundhak 6 % tanpa signifikansi. Efek iki tetep ketok nganti 4 minggu sawisé pamungkas dosis. Nanging asil iki mung kanggo siji peptida bermerek lan siji populasi, ora kanggo kabeh bubuk kolagen.

**Approach: Human outcome. Palette: warm (B).**

Extreme close-up, slightly high angle, of a woman's scalp parting in her 40s. Dense, glossy chestnut-brown hair is split by a fine comb. Short new hairs rise from the visible scalp skin, and a few strands catch the light. Faces and identity are out of frame. Low golden-hour window light enters from camera left and rim-lights the strands in honey and copper. Shadows stay warm brown, with no blue cast. The shallow depth of field blurs the background hair into soft amber bokeh. A thin steel trichoscopy probe tip sits at the edge of the frame, and a tiny electric green LED glints on its housing as the only accent. The mood is hopeful but scrutinizing, like a clinical check-up with a cautious eye.
supplements

NMN Nambah Kerapatan Rambut 57 % ing Uji Coba Manungsa—Ana Kecualian Gedhe

BY NOVA CHEN ·

NMN, suplemen sing nambah NAD+ lan dadi favorit para penggemar umur panjang, saiki kaping pisan dipriksani efeké marang pertumbuhan rambut manungsa. Ing uji pilot 12 minggu sing kalebu 15 wanita umur 40–50 taun, kerapatan rambut ing fase anagen mundhak saka 55,9 dadi 87,7 rambut/cm², déné diameter rambut nambah saka 75,3 dadi 78,8 µm. Para peserta uga nglaporake peningkatan kilau, elastisitas, lan volume rambut. Senadyan mangkono, ora ana grup plasebo, ukuran sampel cilik, lan penulis kagandheng karo pemasok NMN. Ing ngisor iki angka‑angka sing ditampilaké, apa sing ora ditampilaké, lan sapa sing kudu ngenteni.

Approach: conceptual metaphor. Palette: D, bold color field.

A single brass dial-style dosing syringe-free metaphor: a tall glass measuring cylinder, photographed straight on at eye level, filled with clear liquid and a column of stacked white tablets that rises in even steps and then stops short of a thin painted line, as if a staircase of doses has been held back. The glass cylinder stands on a glossy surface against a saturated tomato-red seamless backdrop. Soft large-softbox light from the left gives crisp highlights on the glass and a clean, short shadow on the right. A tiny electric green (#00e676) rubber band circles the cylinder near the top limit. Shallow depth of field blurs a second, taller cylinder in the background. Mood: controlled, restrained, quietly hopeful. No text, no markings legible.
supplements

Magtein Nguwasi Lonjakan Dosis Opioid ing Pasien Kanker? Apa Sing Ditemokaké Ing Penelitian

BY NOVA CHEN ·

Suplemen magnesium sing paling misuwur kanggo ningkataké memori lan turu iki saiki muncul ing uji klinis nyeri kanker. Ing 83 pasien kanker stadium lanjut sing nggunakake opioid oral, sing njupuk magnesium‑L‑threonate (L‑TAMS, senyawa sing dipasaraké minangka Magtein) mung nambah dosis morfin separo saka sing njupuk plasebo sajroning 90 dina. Suplemen iki uga nyuda konstipasi sing disebabaké opioid. Nanging iki mung studi cilik ing siji pusat lan populasi sing khusus, mula ora dadi alesan kanggo ngowahi obat tanpa pitutur dhokter. Ing ngisor iki apa sing ditemokaké, apa sing ora, lan sapa sing kudu rembugan karo klinisi.

Approach: conceptual metaphor. Palette: D, bold color field.

A single AA-style cylindrical battery stands upright, fully charged, on a seamless saturated mustard-yellow backdrop. Beside it sits a matching, untouched, slightly dusty glass jar of marbles, so the charge shows no visible link to any result. More precisely, a bright tomato-red extension cord plugs into the battery's top. Its other end curls away unconnected, lying on the floor beside an unlit incandescent bulb. A small electric green LED glows on the battery's side as the only green accent. Camera: low three-quarter angle, 50mm lens, shallow depth of field, with the bulb softly blurred in the foreground. Lighting: hard, clean studio key light from the upper left, with crisp shadows falling to the right on the yellow surface. Mood: puzzled, wry, a full power source that fails to light anything.
supplements

Nicotinamide Riboside Nggedhekake NAD+ Kapindho Nanging Gagal Nambah Memori

BY NOVA CHEN ·

Suplemen iki nambahake tingkat molekul kunci ing getih nganti kapindho, nanging ora ana peningkatan ing memori. Ing uji coba acak 12 minggu marang wong tuwa sing duwe amnestic mild cognitive impairment, nicotinamide riboside munggahake NAD+ loro kaping nanging ora ngowahi kognisi, aliran getih otak total, utawa tekanan darah. Ana siji petunjuk eksploratori babagan aliran getih ing hippocampus, nanging isih adoh saka bukti kuat. Ing ngisor iki apa sing dituduhake studi iki, watesane, lan apa tegese yen sampeyan mikir arep tuku NAD+ booster.

This page is available in